IMAX’s Strategic Positioning and Growth Potential Drive Buy Rating

In a report released today, Steve Frankel from Rosenblatt Securities reiterated a Buy rating on IMAX (IMAX – Research Report), with a price target of $35.00.

Steve Frankel has given his Buy rating due to a combination of factors that highlight IMAX’s strong position in the market and its growth potential. The company is benefiting from a robust lineup of films, which is among the strongest in recent years, and is successfully building closer ties with studios and directors. This strategic positioning is helping IMAX gain market share as audiences increasingly prefer its superior viewing experience.
Additionally, IMAX’s stock is attractively valued, trading at a modest multiple compared to its pre-pandemic levels, which suggests room for appreciation. The company also has a promising growth trajectory, supported by a solid backlog of new locations and innovative strategies to boost box office revenue, such as local language films and alternative content. Furthermore, IMAX’s high-margin business model generates strong cash flows, enabling significant share repurchases, which enhance shareholder value.

In another report released on June 13, Roth MKM also maintained a Buy rating on the stock with a $36.00 price target.

Based on the recent corporate insider activity of 30 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of IMAX in relation to earlier this year.